Here’s Why Baron Health Care Fund Exited AbbVie (ABBV)
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
Abbvie Inc. (ABBV)
Market is closed
News
- First
- << Previous
- 131 - 140
- Next >>
12 Best Low Volatility Stocks to Buy Now
In the first half of 2023, global economic growth picked up pace, reaching 2.8%.
5 Best July Dividend Stocks To Buy
In this article, we discuss 5 best July dividend stocks to buy.
11 Best Medical Stocks Under $10
In this piece, we will take a look at the eleven best medical stocks under $10.
10 Personalized Medicine Stocks Billionaires Are Loading Up On
In this article, we will take a look at the 10 personalized medicine stocks billionaires are purchasing.
Top 30 S&P 500 Stocks by Index Weight
In this article, we discuss the top 30 S&P 500 stocks by index weight.
Top 20 Most Profitable Pharmaceutical Companies In The World
In this article, we will be covering the top 20 most profitable pharmaceutical companies in the world.
Should You Invest in AbbVie (ABBV)?
Harding Loevner, an asset management company, released its “Global Equity Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here.
S&P 500 Dividend Aristocrats List: Top 10 Picks by Hedge Funds
In this article, we will discuss the 10 best dividend aristocrat stocks sorted by hedge fund popularity.
5 Best Healthcare Stocks To Buy Now
On May 19, AbbVie Inc. (NYSE:ABBV) announced that the US Food and Drug Administration (FDA) had approved its blood cancer therapy for adult patients.
- First
- << Previous
- 131 - 140
- Next >>
Billionaire Hedge Funds
